Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

SHE:002390 Revenue

Guizhou Xinbang Pharmaceutical had revenue of 1.26B CNY in the quarter ending March 31, 2026, a decrease of -12.34%. This brings the company's revenue in the last twelve months to 5.44B, down -7.63% year-over-year. In the year 2025, Guizhou Xinbang Pharmaceutical had annual revenue of 5.62B, down -6.84%.

• Revenue (ttm): 5.44B
• Revenue Growth: -7.63%
• P/S Ratio: 1.01
• Revenue / Employee: 1.16M
• Employees: 4,702
• Market Cap: 5.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.62B	-412.70M	-6.84%
Dec 31, 2024	6.03B	-428.58M	-6.63%
Dec 31, 2023	6.46B	110.82M	1.75%
Jan 1, 2023	6.35B	-121.84M	-1.88%
Jan 1, 2022	6.47B	626.24M	10.71%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 7, 2026

Data Sources Report a data error